Akebia Therapeutics | AKBA - 股票



金融业
股票价格
USD
资产
USD 376.57M
现金及等价物
USD 184.84M
销售成本
USD 10.34M
流动资产
USD 252.96M
流动负债
USD 162.94M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 32.61M
销售毛利
USD 47.28M
债务利息支出
4.83M
贷款资金
USD 48.25M
市值
USD 316M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 15.61M
贸易债权人
USD 21.19M
应收帐款人
USD 47.03M


股票 更改 日
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Akebia Therapeutics USD 15.61M 3.03M 2025-12
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.19B 39M 2026-03
Ardelyx USD 128.02M 110.29M 2026-03
Astellas Pharma JPY 297.26B 9.92B 2025-03
AstraZeneca USD 6.57B 13M 2026-03
Bayer EUR 12.33B 221M 2025-09
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Celltrion KRW 2.71T 121.94B 2025-06
Cspc Pharmaceutical CNY 2.87B 259.23M 2025-06
Exelixis USD 21.69M 5.71M 2025-12
Fresenius Medical Care EUR 2.14B 54.28M 2025-12
GlaxoSmithKline GBP 6.16B 233M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
J&J USD 14.58B 392M 2026-03
Kangmei Pharma CNY 2.45B 12.27M 2025-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Laboratorios Farma EUR 327.67M 2.28M 2025-06
Lexicon Pharmaceuticals USD 168K 33K 2025-06
Medical Developments International AUD 9.45M 679K 2025-06
Moderna USD 146M 7M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Organigram Holdings CAD 132.71M 8.76M 2025-12
Pharma Mar EUR 53.12M 2.48M 2026-03
PTC Therapeutics USD 79.65M 26.96M 2025-12
Qiagen NV USD 301.89M 11.66M 2025-12
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Sartorius EUR 827.1M 34.9M 2026-03
Sino Biopharmaceutical CNY 1.84B 156.17M 2024-06
Tilray USD 282.79M 11.9M 2025-06
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Zealand Pharma A/S 10.7M 9.9M 2024-12
Zz Pientze Pharmaceu CNY 6.28B 553.86M 2026-03